Enwei Pharmaceutical: It is expected that the net profit in 2025 will increase by 50.68% to 77.35% compared to the previous year.

Enwei Pharmaceuticals announced that it is expected to achieve a net profit of 56.5 million to 66.5 million yuan in 2025, representing a year-on-year increase of 50.68% to 77.35%. During the reporting period, it is estimated that the impact of non-recurring gains and losses on net profit will be approximately 7.5 million yuan. The main reasons for the increase in performance in 2025 are the growth of main business income leading to an increase in net profit and a reduction in the amortization of equity incentive plan costs.